{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.29","value":"0.37"},{"groupId":"OG001","spread":"0.05","value":"0.13"}]}],"title":"CRP, Genistein cycles"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.26","value":"0.33"},{"groupId":"OG001","spread":"0.10","value":"0.15"}]}],"title":"CRP, Placebo cycles"}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"Genistein daily throughout chemotherapy cycles 1 and 2, and placebo daily during chemotherapy cycles 3 and 4\n\nGenistein: Estrogen-like compound (isoflavone) derived from soybeans\n\nPlacebo: Pill that contains no medicine","id":"OG000","title":"Arm A: Genistein Followed by Placebo"},{"description":"Placebo daily throughout chemotherapy cycles 1 and 2, and genistein daily during chemotherapy cycles 3 and 4\n\nGenistein: Estrogen-like compound (isoflavone) derived from soybeans\n\nPlacebo: Pill that contains no medicine","id":"OG001","title":"Arm B: Placebo Followed by Genistein"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Once before treatment starts and then four more times while the study drug is being taken, an 8 - 16 week period if there are no chemotherapy delays","title":"Serum Marker Levels of Inflammation C-reactive Protein (CRP; mg/dL) During Cycles of Chemotherapy","type":"SECONDARY","unitOfMeasure":"mg/dL"}